Artificial Intelligence in Medicine: AI Predicts Metastasis Better than NCCN Guidelines
What’s the best way to determine if a high-risk prostate cancer (PCa) patient is likely to have metastasis? Researchers have been busy analyzing genetic variants or other biomarkers for their prognostic value. Since no one factor has emerged as a top predictor, most doctors have relied on up-to date guidelines from the National Comprehensive Cancer keep reading